Although human studies are time-consuming and lack the ability to ascertain the mechanistic underpinning of the metabolic, inflammation, and direct effects of GLP-1RAs, basic studies using genetic rodent models work together with clinical and population-based research
The FDA said patients should not use a compounded GLP-1 drug if an approved drug, like Wegovy, is available
Mistake 3: inadequate hold time Already covered extensively, but worth repeating
GLP-1 medications suppress appetite, which often leads to skipped meals and inadequate protein intake
Phentermine (Adipex-P): What It Is: Sympathomimetic amine (stimulant) Appetite suppressant Oldest weight loss medication still available Effectiveness: Average Weight Loss: 5-7% of body weight Short-term use only (FDA-approved for 12 weeks) Weight often regained after stopping Mechanism: Stimulates norepinephrine release Decreases appetite Increases energy expenditure Side Effects: Increased heart rate and blood pressure Insomnia Nervousness, anxiety Dry mouth Constipation Potential for dependence Major Limitations: Controlled substance (Schedule IV) FDA-approved for short-term only (12 weeks) Not a long-term solution Cardiovascular concerns Risk of abuse Cost: Generic: $20-$50/month Usually not covered by insurance Who Should Consider: Need short-term appetite suppression Kickstart weight loss before switching to long-term option Cant afford other medications No cardiovascular disease or substance abuse Most experts dont recommend phentermine due to short-term limitation and rebound weight gain
Ozempic and the GLP-1 Drug Landscape Pfizer has officially halted the development of its experimental once-daily weight loss pill, danuglipron, due to a case of liver injury in a clinical trial participant
